Announcements Trials
Browse Landscape

Phase

Phase 1 4

Status

Completed 4

Sponsor Class

OTHER 3NIH 1

Study Type

Interventional 4

Sponsor

Cancer Type

Other hematologic neoplasm 6Lymphoid 6Other solid neoplasm 4Dermatologic 4Genitourinary 2Plasma cell 1Classical hematology 1

Conditions

Unspecified Adult Solid Tumor, Protocol Specific 4

Interventions

Cisplatin 70Paclitaxel 68pembrolizumab 65Carboplatin 61Irinotecan 59Injections 53Gemcitabine 53Docetaxel 49Fluorouracil 35Cyclophosphamide 35Pemetrexed 34Oxaliplatin 31Capecitabine 30Bevacizumab 29Leucovorin 27atezolizumab 23Nivolumab 23tislelizumab 19Etoposide 18Cetuximab 17durvalumab 16Temozolomide 16Bortezomib 16alvocidib 15Topotecan 15olaparib 14Sorafenib 14Rifampin 14Itraconazole 14Erlotinib Hydrochloride 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 1 × bryostatin 1 × Other solid neoplasm × Clear all
NCT00004144 2014-04-24

Bryostatin 1 Plus Gemcitabine in Treating Patients With Advanced Cancer

Barbara Ann Karmanos Cancer Institute

Phase 1 Completed
36 enrolled
Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00003108 2013-07-18

Cisplatin Plus Bryostatin 1 in Treating Patients With Advanced Cancer

National Cancer Institute (NCI)

Phase 1 Completed
Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00003242 2013-06-24

Bryostatin 1 Plus Paclitaxel and Cisplatin in Treating Patients With Advanced Solid Tumors

Memorial Sloan Kettering Cancer Center

Phase 1 Completed
Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00003132 2012-11-09

Bryostatin 1 Plus Cisplatin in Treating Patients With Metastatic or Unresectable Cancer

NYU Langone Health

Phase 1 Completed
Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

Data powered by HemOnc (CC BY 4.0) Colophon âš¡